报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 3.38% | 45.69% | -67.25% | 14/129 | 1.05% | 迈瑞医疗 | 7.06% | 行业排名> |
2024-12-31 | 10.32% | 70.86% | 26.94% | 27/129 | 2.96% | 迈瑞医疗 | 31.95% | 行业排名> |
2024-09-30 | 8.13% | 94.96% | 89.95% | 32/129 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 4.28% | 176.13% | 84.48% | 44/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 2.32% | 79.84% | -61.59% | 42/129 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 6.04% | 48.77% | 44.84% | 63/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 4.17% | -18.87% | 169.03% | 71/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 1.55% | -39.22% | 20.16% | 89/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.29% | 4.03% | -68.23% | 76/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 4.06% | -23.97% | -21.01% | 93/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 5.14% | -36.7% | 101.57% | 83/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 2.55% | -45.63% | 105.65% | 89/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 1.24% | -44.89% | -76.78% | 80/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 5.34% | -23.71% | -34.24% | 105/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 8.12% | 62.08% | 73.13% | 71/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 4.69% | 2% | 108.44% | 83/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 2.25% | 118.45% | -67.86% | 69/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 7% | 76.32% | 39.72% | 99/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 5.01% | 2% | 386.41% | 67/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-03-31 | 1.03% | 2% | -74.06% | 58/129 | 3.4% | 博拓生物 | 108.13% | 行业排名> |
2019-12-31 | 3.97% | 291.79% | 291.79% | 100/129 | 14.38% | 圣湘生物 | 29.33% | 行业排名> |
2018-12-31 | -2.07% | 89.77% | 89.77% | 100/129 | 12.98% | 健尔康 | 84.09% | 行业排名> |
2017-12-31 | -20.23% | 2% | 2% | 101/129 | 13.82% | 祥生医疗 | 28.56% | 行业排名> |